Toxicology Basics: How Exposure Becomes Harm
Toxicology connects a chemical exposure to a biological effect.
How to use this page
Contact → absorption → distribution and metabolism → dose at the target → biological effect.
This article explains that sequence. For individual chemicals, their workplace uses and characteristic health effects, use the companion Industrial Toxicology Reference.
- Sections 1 to 3 cover definitions, routes and what the body does to a chemical; 4 and 5 cover dose, time and mechanisms; 6 and 7 cover allergy, cancer and developmental harm; 8 and 9 cover interactions and limit labels; 10 and 11 cover evidence and an order of work.
- Original wording, not a copy of any course text, BGC material or standard. The worked example is a teaching exercise, and the exposure-limit labels are described, not reproduced; current ACGIH values are not shown. Source links are in the text and listed on the CIH References page.
01 Separate Exposure, Dose, Toxicity and Risk
Four different questions, and the difference between a local and a systemic effect.
| Concept | Question it answers |
|---|---|
| Exposure | What contact occurred, by which route and for how long? |
| Absorbed dose | How much entered the body? |
| Toxicity | What harmful effects can the substance produce under specified conditions? |
| Risk | How likely and serious is harm under the actual exposure conditions? |
| Xenobiotic | Is the chemical foreign to the body? This does not automatically mean harmful at every dose. |
A concentration in air is not the same as an absorbed dose. Duration, breathing rate, absorption and other routes can change the amount reaching the body. A hazard label alone does not establish the risk of a particular task.
Local effects occur at the contact site. Systemic effects follow absorption and distribution and can occur elsewhere. An inhaled chemical may injure the kidneys; the entry route is not necessarily the target organ.
02 Understand the Routes of Entry
Inhalation, skin, ingestion and injection, and what a skin notation does and does not mean.
| Route | Main assessment question |
|---|---|
| Inhalation | Which gases, vapours or airborne particles enter the breathing zone? |
| Skin absorption | Can contact contribute to the dose inside the body? |
| Ingestion | Can contaminated hands, food or other material introduce the substance into the digestive tract? |
| Injection or penetration | Can a puncture, sharp or high-pressure incident introduce material through the skin? |
Skin contact can cause direct irritation, sensitization or systemic uptake. These are distinct outcomes. A chemical may enter through the skin without producing an obvious rash.
An ACGIH Skin notation highlights potentially significant dermal contribution to overall exposure; it is not simply an allergy label. NIOSH uses its own notation framework distinguishing direct, systemic and sensitizing effects. Read the definitions of the system being used. NIOSH—Skin Notation Profiles
03 Follow ADME: What the Body Does to the Chemical
Absorption, distribution, metabolism and excretion, with half-life and the idea of bioactivation.
Toxicokinetics describes how a substance moves through and changes within the body. ADME is its basic organizing framework.
| Stage | Meaning | Why it matters |
|---|---|---|
| Absorption | Entry into the body across a biological barrier | Contact does not mean the whole contacted amount is absorbed |
| Distribution | Movement to tissues through circulation and other processes | Different tissues receive or retain different amounts |
| Metabolism / biotransformation | Enzymatic conversion into metabolites | Products may be less toxic or more toxic |
| Excretion | Removal of a substance or its metabolites | Removal rate influences how long exposure-related material persists |
Distribution is carried by the blood, and some chemicals collect in storage sites: lead in bone, and lipid-soluble solvents and PCBs in fat. Half-life is the time for the body burden to fall by half. A long half-life lets a chemical build up over repeated exposure, and the timing of a biological sample matters most for chemicals with a short half-life (for example an end-of-shift sample). Source: NLM ToxTutor.
Membrane transport versus chemical properties
- Passive diffusion: movement down a concentration gradient without direct energy expenditure.
- Facilitated diffusion: movement down a gradient through suitable membrane proteins.
- Active transport: energy-dependent movement that can act against a gradient.
- Lipid solubility: a property influencing passage through lipid membranes, not a transport mechanism itself.
Metabolism is not always detoxification
Biotransformation can reduce toxicity, but bioactivation produces a more harmful species. For example, metabolism contributes to the peripheral nerve toxicity of n-hexane. This is why a chemical's immediate effects can differ from effects after repeated exposure. NIOSH—Organic Solvent Neurotoxicity
Bioaccumulation means buildup within an organism. Biomagnification means increasing concentrations through higher levels of a food chain. Neither term means chemical conversion.
04 Relate Dose and Time to the Measured Effect
Dose-response vocabulary, LD50, LC50, NOAEL and LOAEL, with a worked interpolation.
Acute and chronic describe exposure or effect time patterns; they do not mean mild and severe. A brief exposure can be fatal, and repeated exposure may produce delayed disease. Some effects are reversible; others persist after exposure ends.
Dose–response vocabulary. The dose makes the poison (Paracelsus): the size of the effect, or the share of people affected, rises with dose, and every substance is toxic at some dose, so hazard needs exposure. ED₅₀ and TD₅₀ are the doses producing a given effect (ED) or a toxic effect (TD) in 50% of the group; comparing the two curves shows the margin between effect and harm. Most non-cancer effects have a threshold dose below which no effect is expected, whereas genotoxic carcinogens are usually treated as having no safe threshold, which is why exposure is kept as low as reasonably achievable.
| Measure | Interpretation | Limitation |
|---|---|---|
| LD₅₀ | Estimated dose causing death in half the test population under specified conditions | Describes acute lethality, not overall safety |
| LC₅₀ | Estimated exposure concentration causing death in half the test population for a specified duration | Concentration, duration, species and conditions must be retained |
| NOAEL | Highest tested dose with no observed adverse effect in that study | Does not prove universal absence of harm below that dose |
| LOAEL | Lowest tested dose with an observed adverse effect in that study | Depends on tested doses and measured endpoints |
Compare LD₅₀ values only with attention to route, species and test conditions. Under comparable conditions, a lower value indicates greater acute lethal toxicity. It does not automatically mean greater workplace risk. Occupational risk also depends on exposure conditions and effects such as chronic toxicity that LD₅₀ does not describe.
Worked example
A hypothetical study reports 35% mortality at 10 mg/kg and 65% at 15 mg/kg. With an explicit linear-interpolation assumption:
The result rounds to 13 mg/kg only when whole-number rounding is requested. Actual dose–response modelling need not be linear.
05 Understand How Chemicals Cause Harm
Twenty mechanisms and effect categories, and four presentations that look alike.
Toxicodynamics describes what a chemical does to biological systems. Start with what the chemical does to the body, then learn the chemical–effect pair. Some rows describe a specific mechanism; others group effects by the organ damaged. These categories overlap, so one substance can appear in several rows.
Reading rule: these are possible effects at sufficient exposure, not symptoms that prove a diagnosis. Route, dose, duration, chemical form and individual susceptibility matter, and a relatively low-toxicity substance should not be forced into a severe-hazard category.
| Mechanism or effect category | What happens in the body? | Teaching examples | Recognition clue |
|---|---|---|---|
| Simple asphyxiation: oxygen displacement | A gas replaces part of the air, reducing the oxygen available to breathe. | Nitrogen, argon, helium, hydrogen, methane, ethane (section 07) | Less oxygen in the air. Some also present fire or explosion hazards. |
| Chemical asphyxiation: impaired oxygen transport or use | The chemical interferes with oxygen delivery or with the cells' ability to use it. Atmospheric oxygen can remain normal. | CO: carboxyhemoglobin formation. HCN and H₂S: inhibition of cellular respiration (section 07) | Oxygen may be present, but delivery or use fails. H₂S also causes irritation and other toxic effects. |
| Hypercapnia: excessive carbon dioxide | Excess CO₂ disrupts acid–base balance and affects breathing, the brain and cardiovascular function. It can also displace oxygen. | Carbon dioxide | Too much CO₂, not merely too little O₂. |
| CNS depression (narcosis) | Sufficient exposure depresses brain function, impairing alertness and coordination; severe exposure can impair breathing. | Acetone, MEK, toluene, xylene, isopropanol and several chlorinated solvents (02, 04) | Dizzy, then drowsy, then poorly coordinated. Normal atmospheric oxygen does not exclude solvent toxicity. |
| Acetylcholinesterase inhibition | Inhibition of the enzyme that breaks down acetylcholine lets this nerve messenger accumulate, overstimulating affected nerve connections. | Organophosphate insecticides: parathion, malathion (section 05) | Signals accumulate: pinpoint pupils, salivation, tearing, sweating, twitching and weakness. |
| Neuronal excitation and seizures | Disruption of nerve signalling can produce excessive excitation rather than sedation. The precise mechanism varies by chemical. | Organochlorine insecticides: DDT, chlordane, aldrin (section 05) | Tremors and seizures. Do not assume every pesticide inhibits cholinesterase. |
| Persistent nervous-system injury | Injury to brain cells or peripheral nerves can cause lasting changes in movement, sensation, memory or behavior. | Manganese: movement disorder. Mercury: tremor and behavioral effects. n-Hexane and MnBK: peripheral neuropathy. Lead: peripheral neuropathy (01, 02, 04) | Brain versus peripheral nerves. Chronic nerve injury differs from acute solvent narcosis. |
| Irritation, corrosion and skin defatting | Direct contact damages or inflames tissue. Some solvents remove protective skin oils and cause irritant dermatitis. | Ammonia, formaldehyde, acrolein, chromium(VI) compounds; repeated solvent contact (06, 04) | Damage at the contact site: burning eyes, airway irritation, cracked skin or chemical burns. This does not require allergy. |
| Chemical lung injury and pulmonary edema | Toxic injury to the airways and the lung's air–blood barrier can cause inflammation and fluid leakage into the lungs. Effects may be delayed. | Phosgene, nitrogen dioxide, chlorine, ozone, nickel carbonyl, cadmium fume (section 06) | The lungs are injured, not simply short of oxygen. Early mild symptoms do not exclude later deterioration. |
| Skin or respiratory sensitization | Exposure can establish an immune response; later exposure may trigger allergic skin or respiratory reactions. | Epoxy-system components, nickel and cobalt compounds; TDI and MDI (diisocyanates) | Sensitization first, reaction on re-exposure. Allergic dermatitis and occupational asthma differ from ordinary irritation. |
| Chronic lung inflammation and scarring | Retained material or a persistent immune response damages lung tissue; fibrosis reduces lung flexibility and gas exchange. | Asbestos: asbestosis. Beryllium: immune-mediated granulomatous disease. Cobalt-containing hard-metal dust: interstitial lung disease (section 08) | Fibrosis means scarring. Beryllium disease also involves sensitization; it is not just dust accumulation. |
| Blood and bone-marrow toxicity | Chemicals may suppress blood-cell production, interfere with hemoglobin synthesis or destroy circulating red cells. | Benzene: marrow injury. Lead: impaired heme synthesis. Stibine: hemolysis | Too few cells, impaired hemoglobin production, or destroyed cells. These are different mechanisms. |
| Liver toxicity (hepatotoxicity) | The chemical or its metabolites injure liver cells, potentially causing fatty change, inflammation or necrosis. | Carbon tetrachloride, chloroform; substantial repeated ethanol exposure | Liver-cell injury. This is distinct from liver cancer, although a chemical can have both effects. |
| Kidney toxicity (nephrotoxicity) | Injury to the renal tubules or other kidney structures impairs reabsorption, filtration or waste removal. | Cadmium, inorganic mercury, uranium; ethylene glycol metabolites | Cadmium: tubular protein loss. “Nephrotoxic” means harmful to the kidneys, not exclusively glomerular damage. |
| Toxic metabolite formation and metabolic acidosis | Metabolism converts the parent chemical into products that contribute to acid accumulation and organ injury. | Methanol: formate, visual injury. Ethylene glycol: acidic metabolites and renal injury (section 03) | Metabolism can increase toxicity. Methanol points to the eyes; ethylene glycol to acidosis and the kidneys. |
| Cardiac sensitization and heart-muscle injury | Some halocarbons make the heart more susceptible to abnormal rhythms, including responses to adrenaline. Heart-muscle disease is documented for cobalt after very heavy oral intake, not as a usual result of workplace inhalation. | Certain halocarbon solvents and refrigerants (for example FC-113). Cobalt: cardiomyopathy after heavy oral intake | Abnormal rhythm or heart-muscle injury. Cardiac sensitization is not an allergic reaction. |
| Reproductive and developmental toxicity | Exposure can impair fertility or harm the developing embryo, fetus or child. The affected process depends on the chemical and timing. | DBCP: impaired sperm production. Lead: reproductive and developmental effects. Methylmercury: developmental neurotoxicity | Fertility and development are different endpoints. Developmental toxicity is broader than structural birth defects. |
| Endocrine disruption | Hormone signalling is altered. | Substance-specific; verify each agent before naming it | A mechanism distinct from every reproductive effect. Do not label every reproductive effect endocrine. |
| Cancer (carcinogenicity) | Chemicals can promote cancer through DNA damage and/or other processes that alter cell growth and regulation. Risk depends on the substance and the exposure. | Benzene: leukemia. Vinyl chloride: liver angiosarcoma. Asbestos: mesothelioma and lung cancer. Arsenic, chromium(VI) and certain nickel compounds | Learn the agent–cancer pairing. Carcinogenicity does not mean every exposed person develops cancer. |
| Persistent organic pollutant effects | Certain persistent compounds act on receptor signalling and several organs. Effects differ substantially between individual congeners and mixtures. | PCBs; chlorinated dioxins and dibenzofurans | Persistence does not mean identical toxicity. Certain compounds cause chloracne and immune, developmental or other systemic effects. |
Sources: Nervous-system effects: NIOSH, Organic Solvent Neurotoxicity (CIB 48); ATSDR, Toxicological Profile for Diazinon. Skin injury and sensitization: NIOSH Skin Notation Profiles, for example glutaraldehyde and epichlorohydrin. Chemical-specific effects and target organs: NIOSH Pocket Guide, stibine; acetone. Chronic lung disease: ATSDR, Toxicological Profile for Beryllium. Toxic metabolites: NIOSH Pocket Guide, methyl alcohol; ATSDR, Toxicological Profile for Ethylene Glycol. Cardiac sensitization: 1988 OSHA PEL Project, FC-113; cobalt: ATSDR, Toxicological Profile for Cobalt. Reproductive effects and persistent pollutants: ATSDR, Toxicological Profile for DBCP; ATSDR, Clinician Brief: PCBs. Cancer: National Cancer Institute, Cancer-Causing Substances in the Environment.
Four similar-looking presentations
A dizzy worker may have solvent-related CNS depression, impaired oxygen delivery, impaired cellular oxygen use, oxygen deficiency or a nonchemical condition. The symptom alone cannot decide which.
Two contrasts help:
- CO versus cyanide: one important CO mechanism is impaired oxygen delivery through carboxyhaemoglobin; cyanide interferes with cellular respiration.
- Solvent narcosis versus cholinergic toxicity: narcosis depresses function; AChE inhibition lets acetylcholine accumulate, affecting glands, muscle connections and the CNS. Pinpoint pupils, excessive secretions and twitching support a different pattern from drowsiness alone.
AChE inhibition is not exclusively parasympathetic: nicotinic and central effects matter too. ATSDR—Cholinesterase Inhibitors
For chemical lists and specific organ associations, return to the Industrial Toxicology Reference. The examples here illustrate mechanisms; the Reference holds the chemical rows.
06 Distinguish Irritation, Allergy and Sensitization
Direct tissue damage versus an immune response, and Type I versus Type IV timing.
| Feature | Direct irritation | Allergic response |
|---|---|---|
| Main process | Direct tissue damage or inflammation | Immune-mediated reaction |
| Prior sensitization | Not required | Sensitization is part of the process |
| Example pattern | Skin dryness and irritation after repeated solvent contact | Dermatitis or asthma triggered in a sensitized person |
| Interpretation | Depends on contact and tissue response | May be triggered at exposure levels tolerated by nonsensitized people |
Hypersensitivity reactions are classified into four types by the immune mechanism that causes the injury (the Gell and Coombs system).
| Type | What causes the injury? | Typical timing after re-exposure | Examples | Memory aid |
|---|---|---|---|---|
| I: Immediate | IgE antibodies trigger mast cells to release histamine and other mediators | Usually minutes; later reactions can follow | Allergic asthma, hives, anaphylaxis | IgE → immediate release |
| II: Antibody-mediated | IgG or IgM targets antigens attached to cells or tissues, causing injury or altered function | Variable: hours to days | Immune hemolytic anemia; incompatible blood transfusion reaction | Antibodies attack attached targets |
| III: Immune-complex | Antibodies bind soluble antigens; the resulting complexes deposit in tissues and trigger inflammation | Often hours; varies by condition | Serum sickness; contributes to hypersensitivity pneumonitis | Complexes collect → inflammation |
| IV: Delayed | T cells, rather than antibodies, drive inflammation or directly damage cells | Commonly 24–72 hours | Allergic contact dermatitis; contributes to hypersensitivity pneumonitis | T cells take time |
Timing helps recognition, but the immune mechanism defines the type. Conditions can involve more than one mechanism. Immediate allergy to latex proteins (type I) and delayed allergy to certain glove additives (type IV) illustrate the occupational contrast. Timing is a clue, not a diagnosis. Source: Merck Manual Professional Edition, Overview of Allergic and Atopic Disorders.
Asthma and hypersensitivity pneumonitis are also different: asthma principally involves variable airway obstruction, whereas HP involves immune-mediated inflammation of lung tissue and small airways. Do not label all respiratory sensitization as the same disease.
07 Separate Mutations, Cancer and Developmental Harm
Related endpoints that are not interchangeable, the Ames test and the IARC and ACGIH scales.
| Term | What it describes |
|---|---|
| Mutagenicity | Ability to produce genetic mutations |
| Carcinogenicity | Capacity to cause cancer under relevant conditions |
| Teratogenicity | Structural developmental malformations |
| Developmental toxicity | Effects on development, including survival, growth, structure or function |
| Reproductive toxicity | Effects on reproductive function and/or development |
A mutagen is not automatically proven to cause cancer in humans. Developmental toxicity is broader than malformations, and impaired adult fertility differs from fetal injury.
What the Ames test measures
The Ames test is a bacterial reverse-mutation assay. Selected strains cannot perform a function needed for growth under selective conditions. Mutations restoring that function produce revertant colonies. An increase relative to controls can indicate mutagenic activity. Conditions with and without metabolic activation help detect effects of parent chemicals and metabolites. A positive result alone does not establish human cancer risk. OECD—Test Guideline 471
A procarcinogen requires metabolic activation. A cocarcinogen enhances another agent's carcinogenic action. Specific definitions and evidence should guide use of these terms.
Memory aid:
- Co- = together: helps another agent produce cancer.
- Pro- = precursor: must be converted into an active form.
Cancer classification scales
IARC and ACGIH classify carcinogens on different scales. They are read side by side for recall; they are not formally equivalent.
| IARC group | Meaning | ACGIH notation | Meaning |
|---|---|---|---|
| Group 1 | Carcinogenic to humans | A1 | Confirmed human carcinogen |
| Group 2A | Probably carcinogenic to humans | A2 | Suspected human carcinogen |
| Group 2B | Possibly carcinogenic to humans | A3 | Confirmed animal carcinogen with unknown relevance to humans |
| Group 3 | Not classifiable | A4 | Not classifiable as a human carcinogen |
| — | — | A5 | Not suspected as a human carcinogen |
08 Consider Interactions Between Exposures
Additive, synergistic, antagonistic and potentiation, and when a mixture screen applies.
| Interaction | Concept | Example |
|---|---|---|
| Additive | Combined effect matches the expected sum under the chosen model | Two organophosphates inhibiting cholinesterase |
| Synergistic | Combined effect exceeds the expected additive effect | Smoking and asbestos: lung cancer risk multiplies |
| Antagonistic | One agent reduces another's effect | Antidotes; chelating agents for metals |
| Potentiation | Conventionally, an agent with little or no effect on an endpoint alone increases another agent's toxicity | Isopropanol increases carbon tetrachloride liver damage |
Source: NLM ToxTutor.
These labels require a defined endpoint and evidence. Two substances producing similar effects are not automatically synergistic. Similarly, “enhancement” alone does not establish the strict definition of potentiation.
An additive mixture screen may use $\sum (C_i/L_i)$, but only where the model and limits are appropriate. The terms require compatible averaging periods. Do not automatically sum unrelated endpoints or assume the equation accounts for synergy. Detailed calculation and limit selection belong in exposure assessment.
Chemical exposure and physical hazards can also interact. Ototoxic chemicals and noise illustrate why assessing one hazard alone may miss part of the risk. NIOSH—Chemical-Induced Hearing Loss
09 Read Exposure-Limit Labels Correctly
TWA, STEL, ceiling, skin, sensitizer, BEI and IDLH mean different things.
An exposure limit is only meaningful with its label, averaging period and source.
| Label | Meaning | Why it matters |
|---|---|---|
| TWA | Average over a shift: 8 hours for ACGIH TLVs and OSHA PELs; up to 10 hours (40-hour week) for NIOSH RELs | The same substance can carry different averaging periods |
| STEL | A 15-minute TWA not to be exceeded at any time in the day. ACGIH also limits STEL-level exposures to 4 a day, at least 60 minutes apart | Protects against irritation and acute effects that a TWA would average away |
| Ceiling (C) | Never to be exceeded. For OSHA, if instantaneous monitoring is not feasible, assess it as a 15-minute TWA | Suited to fast-acting irritants and asphyxiants |
| Skin notation | Skin absorption can add meaningfully to the dose | Air sampling alone can under-state the dose; consider gloves and biological monitoring |
| Sensitizer (DSEN, RSEN) | Can cause skin or respiratory sensitization | A limit based on sensitization is not meant to protect workers who are already sensitized |
| BEI | Biological Exposure Index: a reference value for a chemical or metabolite in urine, blood or breath | Reflects uptake from all routes, for the specified chemical and sampling time |
| IDLH | Immediately Dangerous to Life or Health: a respirator-selection and escape value, not a workday limit | Above IDLH, respirator selection moves to supplied-air (SCBA) level protection |
10 Interpret Evidence Without Confusing Exposure and Effect
What an air result, a biological specimen, a biomarker and a symptom can and cannot show.
| Evidence | What it can tell you | What it cannot establish alone |
|---|---|---|
| Air measurement | External inhalation exposure over a sampled interval | Total absorbed dose from all routes |
| Chemical/metabolite in a biological specimen | Internal exposure information | A universal exposure time window for every chemical |
| Effect biomarker | A biological response | The cause without context |
| Functional test | Performance of a system, such as lungs or hearing | A complete exposure history or diagnosis |
| Symptoms | A reason to investigate | A unique chemical identification |
Biomonitoring depends on chemical species, kinetics, sampling time and the question asked. Do not teach “blood = acute, hair = chronic” as a universal rule. Likewise, a negative or normal result must be interpreted within the method's scope.
For sampling methods, SEGs, lognormal statistics and exposure categories, use the separate exposure assessment chapter. This article supplies the toxicological reasoning behind those decisions.
11 Apply the Concepts in Order
Six questions to work through for any chemical exposure.
When evaluating a chemical exposure, work through six questions:
- What is the agent and physical form?
- Which routes and durations matter?
- What dose can reach the relevant tissue?
- Does metabolism reduce or increase the hazard?
- Which mechanism and endpoint are plausible?
- What evidence and controls are needed to make a defensible decision?
Then use the Industrial Toxicology Reference to look up the specific substance, its characteristic effects and relevant workplace sources.
Toxicology Basics — Frequently asked questions
What is the difference between toxicity and risk?
Toxicity is the harmful effects a substance can produce under specified conditions. Risk is how likely and how serious harm is under the actual exposure conditions, so a hazardous substance can carry a low risk when exposure is well controlled.
Does normal oxygen mean a chemical atmosphere is safe?
No. A solvent can depress the nervous system, and a chemical asphyxiant can impair oxygen transport or cellular use, while atmospheric oxygen stays normal. An acceptable oxygen reading does not by itself make an atmosphere safe.
Is metabolism always a way of detoxifying a chemical?
No. Biotransformation can reduce toxicity, but bioactivation can produce a more harmful species. Metabolism contributes to the nerve toxicity of n-hexane, for example.
What is the difference between irritation and sensitization?
Irritation is direct tissue damage or inflammation and needs no prior immune response. Sensitization is an immune response that can cause a reaction on later exposure, sometimes at levels that do not affect people who are not sensitized.
Is a positive Ames test proof that a chemical causes cancer in people?
No. The Ames test is a bacterial reverse-mutation assay. A positive result can indicate mutagenic activity, but it does not by itself establish human cancer risk.